HBM Healthcare Investments - aVenture Asset Manager Research
Location
Zug, CH
Founded
2001
HBM Healthcare Investments AG is a Swiss venture capital firm specializing in the biotechnology, human medicine, diagnostics, and medical technology sectors. The firm primarily focuses on high-potential private companies, with two-thirds of its assets invested in unlisted companies. HBM typically participates in Series A through Series E funding rounds, with significant investments in Series B and C stages.
Notable portfolio companies include Freenome, Harmony Biosciences, and Odyssey Therapeutics. Key partners and decision-makers at HBM bring extensive industry experience, contributing to the firm's robust investment philosophy centered on value creation. HBM Healthcare Investments offers unique value-add services such as strategic guidance and operational support to help portfolio companies scale effectively.
HBM Healthcare Investments - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
HBM Healthcare Investments AG is a Swiss venture capital firm, investing in emerging biotech and medical sectors, focusing on high-potential private companies.
Series E3 (3.7%)
Stage Mix
Series B 32%Series C 28%Series D 20%Series A 16%Series E 4%
Concentration shown as share of disclosed investments by stage.
HBM Healthcare Investments - Similar Investment Firms
